AIM ImmunoTech Inc. (AIM) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 22K | 21K | 26K | 25K | 16K | 45K | 35K | 50K | 40K | 65K | 46K | 42K |
| Revenue Growth % | 37.5% | -53.33% | -25.71% | -50% | -60% | -30.77% | -23.91% | 19.05% | -18.37% | 16.07% | 119.05% | 40% |
| Cost of Goods Sold | 47K | 40K | 122K | 10K | 10K | -51K | 8K | 8K | 66K | 12K | 30K | 0 |
| COGS % of Revenue | 213.64% | 190.48% | 469.23% | 40% | 62.5% | -113.33% | 22.86% | 16% | 165% | 18.46% | 65.22% | - |
| Gross Profit | -25K | -19K | -96K | 15K | 6K | 96K | 27K | 42K | -26K | 53K | 16K | 42K |
| Gross Margin % | -113.64% | -90.48% | -369.23% | 60% | 37.5% | 213.33% | 77.14% | 84% | -65% | 81.54% | 34.78% | 100% |
| Gross Profit Growth % | -516.67% | -119.79% | -455.56% | -64.29% | 123.08% | 81.13% | 68.75% | 0% | -153.06% | -5.36% | -23.81% | 207.69% |
| Operating Expenses | 2.2M | 2.93M | 2.27M | 2.66M | 3.63M | 5.95M | 4.52M | 3.74M | 5.71M | 14.06M | 8.17M | 5.5M |
| OpEx % of Revenue | 10004.55% | 13966.67% | 8726.92% | 10644% | 22656.25% | 13224.44% | 12902.86% | 7472% | 14270% | 21626.15% | 17767.39% | 13102.38% |
| Selling, General & Admin | 1.76M | 1.87M | 1.8M | 1.49M | 2.54M | 4.29M | 3.08M | 2.59M | 3.76M | 10.96M | 5.44M | 2.55M |
| SG&A % of Revenue | 8009.09% | 8904.76% | 6915.38% | 5948% | 15906.25% | 9526.67% | 8797.14% | 5182% | 9392.5% | 16853.85% | 11823.91% | 6071.43% |
| Research & Development | 482K | 1.06M | 607K | 1.17M | 1.08M | 1.66M | 1.44M | 1.15M | 1.95M | 3.2M | 2.73M | 2.95M |
| R&D % of Revenue | 2190.91% | 5061.9% | 2334.62% | 4696% | 6750% | 3697.78% | 4105.71% | 2290% | 4877.5% | 4923.08% | 5943.48% | 7030.95% |
| Other Operating Expenses | -43K | 0 | -136K | 0 | 0 | 0 | 0 | 0 | 0 | -98K | 0 | 0 |
| Operating Income | -2.23M | -2.95M | -2.37M | -2.65M | -3.62M | -5.86M | -4.49M | -3.69M | -5.73M | -14M | -8.16M | -5.46M |
| Operating Margin % | -10118.18% | -14057.14% | -9096.15% | -10584% | -22618.75% | -13011.11% | -12825.71% | -7388% | -14335% | -21544.62% | -17732.61% | -13002.38% |
| Operating Income Growth % | 38.49% | 49.58% | 47.32% | 28.37% | 36.89% | 58.19% | 44.97% | 32.36% | -33.5% | -152.05% | -25.09% | -16.32% |
| EBITDA | -2.18M | -2.91M | -2.31M | -2.59M | -3.5M | -5.79M | -4.43M | -3.63M | -5.68M | -13.95M | -8.1M | -5.38M |
| EBITDA Margin % | -9922.73% | -13852.38% | -8888.46% | -10364% | -21856.25% | -12868.89% | -12645.71% | -7266% | -14190% | -21455.38% | -17617.39% | -12811.9% |
| EBITDA Growth % | 37.58% | 49.77% | 47.79% | 28.68% | 38.39% | 58.48% | 45.38% | 32.48% | -33.62% | -158.93% | -25.25% | -15.32% |
| D&A (Non-Cash Add-back) | 43K | 43K | 54K | 55K | 122K | 64K | 63K | 61K | 58K | 58K | 53K | 80K |
| EBIT | -2.23M | -3.78M | -3.14M | -2.65M | -3.58M | -5.83M | -3.5M | -1.66M | -5.75M | -14M | -7.82M | -4.91M |
| Net Interest Income | -296K | -281K | 2.9M | -139K | -113K | 1.68M | 516K | 2.4M | 9K | 258K | 294K | 318K |
| Interest Income | 8K | 110K | 3.05M | 10K | 11K | 1.81M | 718K | 2.58M | 81K | 258K | 294K | 318K |
| Interest Expense | 304K | 391K | 148K | 149K | 124K | 132K | 202K | 179K | 72K | 0 | 0 | 0 |
| Other Income/Expense | -797K | -1.22M | -919K | -148K | -86K | -112K | 789K | 1.86M | -83K | 1.43M | 341K | 552K |
| Pretax Income | -3.02M | -4.17M | -3.28M | -2.79M | -3.71M | -5.97M | -3.7M | -1.84M | -5.82M | -12.58M | -7.82M | -4.91M |
| Pretax Margin % | -13740.91% | -19880.95% | -12630.77% | -11176% | -23156.25% | -13260% | -10571.43% | -3672% | -14542.5% | -19347.69% | -16991.3% | -11688.1% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -3.02M | -4.17M | -3.28M | -2.79M | -3.71M | -5.97M | -3.7M | -1.84M | -5.82M | -12.58M | -7.82M | -4.91M |
| Net Margin % | -13740.91% | -19880.95% | -12630.77% | -11176% | -23156.25% | -13260% | -10571.43% | -3672% | -14542.5% | -19347.69% | -16991.3% | -11688.1% |
| Net Income Growth % | 18.41% | 30.03% | 11.24% | -52.18% | 36.31% | 52.55% | 52.66% | 62.6% | -58.89% | -186.53% | -22.41% | -1.2% |
| Net Income (Continuing) | -3.02M | -4.17M | -3.28M | -2.79M | -3.71M | -5.97M | -3.7M | -1.84M | -5.82M | -12.58M | -7.82M | -4.91M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.69 | -1.36 | 1.57 | -1.34 | -1.91 | -3.50 | -2.33 | -1.26 | -4.27 | -9.30 | -5.83 | -3.68 |
| EPS Growth % | 63.93% | 61.14% | 167.47% | -6.05% | 55.19% | 62.36% | 60.11% | 65.78% | -55.56% | -180.5% | -21.01% | -0.4% |
| EPS (Basic) | -0.69 | -1.36 | 1.57 | -1.34 | -1.91 | -3.50 | -2.33 | -1.26 | -4.27 | -9.30 | -5.83 | -3.68 |
| Diluted Shares Outstanding | 4.35M | 3.07M | 2.09M | 2.09M | 1.94M | 1.57M | 1.59M | 1.46M | 1.36M | 1.35M | 1.34M | 1.33M |
| Basic Shares Outstanding | 4.35M | 3.07M | 2.09M | 2.09M | 1.94M | 1.57M | 1.59M | 1.46M | 1.36M | 1.35M | 1.34M | 1.33M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |